Coptisine enhances the sensitivity of chemoresistant breast cancer cells by inhibiting the function and expression of ABC transporters
2024

Coptisine Boosts Chemotherapy Effectiveness in Resistant Breast Cancer Cells

publication Evidence: moderate

Author Information

Author(s): Eid Safaa Yehia

Primary Institution: Umm Al-Qura University, Makkah, Saudi Arabia

Hypothesis

Combining coptisine with doxorubicin will enhance doxorubicin's efficacy in resistant breast cancer cells.

Conclusion

Coptisine can reverse multidrug resistance in breast cancer cells, enhancing the effectiveness of doxorubicin.

Supporting Evidence

  • Coptisine significantly enhances doxorubicin cytotoxicity in resistant breast cancer cell lines.
  • The combination of coptisine and doxorubicin shows a synergistic effect.
  • Coptisine inhibits the function of ABC transporters, which are responsible for drug resistance.
  • Coptisine downregulates the expression of genes associated with multidrug resistance.

Takeaway

Coptisine helps make cancer cells more sensitive to treatment, so they can be killed by chemotherapy drugs better.

Methodology

The study assessed the cytotoxicity of coptisine and its ability to enhance doxorubicin effectiveness using MTT assays, flow cytometry, and RT-PCR.

Limitations

Further in vivo studies are needed to confirm the findings and explore the mechanisms of action.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.3389/fphar.2024.1472458

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication